Congress has cut federal funding for public media — a $3.4 million loss for LAist. We count on readers like you to protect our nonprofit newsroom. Become a monthly member and sustain local journalism.
Ask Emily: Beware of unapproved stem cell treatments

A website for five affiliated stem cell clinics hails a "breakthrough" for Parkinson’s Disease: "Stem Cells Replace Damaged Nerves, Reverse Symptoms."
For those of you whose lives — or whose loved ones' lives — have been upended by chronic or incurable conditions such as Parkinson’s, that’s just the kind of breakthrough you’ve been waiting for.
But today, I’m going to pass along some advice about these and other for-profit stem cell treatments that you probably don’t want to hear: "Steer clear of them. They’re probably taking advantage of you and it’s probably unproven," says Lawrence Goldstein, director of the Sanford Stem Cell Clinical Center at UC San Diego Health.
Stem cell science is a relatively new field. Stem cells hold great potential for medicine because of their ability to develop into different types of cells in the body, and to repair and renew tissue.
But so far, the only stem cell treatments approved for wide use in the U.S. involve stem cell transplants from bone marrow or blood for patients with certain cancers and other disorders, says Sidney Golub, director of the Sue and Bill Gross Stem Cell Research Center at the University of California, Irvine.
Meanwhile, dozens of experimental stem cell treatments are being tested across the country in clinical trials on human subjects.
"There are some really exciting developments showing great promise, but they are unproven at present," Golub says.
If most stem cell therapies are unproven, how is it that nearly 600 across the country offer costly stem cell treatments for both cosmetic and medical purposes, ranging from spinal cord injuries to breast augmentation?
California has 113 of these clinics, more than any other state, according to stem cell researchers Leigh Turner of the University of Minnesota and Paul Knoepfler of the University of California, Davis. Florida comes in second with 71, followed by Texas with 37.
Many of these clinics say they use stem cells derived from patients’ own fat and, for related reasons, argue that their treatments are exempt from the U.S. Food and Drug Administration’s rigorous approval process.
Their websites show heart-wrenching testimonials from patients who have undergone treatments and believe they have benefitted. The treatments can cost $15,000, $25,000 or more, and generally aren’t covered by health insurance.
If you’re swayed by the testimonials, if you’ve tried every other treatment, and even if you have the money to burn, you should still steer clear, according to nearly every expert I consulted.
"If somebody is telling you something that’s too good to be true, it’s too good to be true," Golub says.
In addition to spending thousands of dollars on a therapy that may not help, you could experience undesirable medical side effects, they warn.
"The risk is far greater than the potential benefit," says Mary Bass, director of public policy at Americans for Cures, a patient advocacy group that supports stem cell research for chronic diseases and injuries.
"There are really no shortcuts in the scientific discovery process. Shortcuts come at grave cost to patients’ health, now or down the line," Bass says.
The FDA, too, says in a statement for consumers that it is "concerned" that patients may be "vulnerable to unscrupulous providers of stem cell treatments that are illegal and potentially harmful."
Kevin McCormack, director of patient advocate outreach for the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, acknowledges that patients don’t want to hear this kind of advice.
"They’ve often explored every other option and don’t have anything left," McCormack says.
But there may be something you can do, he says: Search for a scientifically sound clinical trial that is testing a stem cell therapy for your condition.
One trustworthy place to look, McCormack says, is the Alpha Stem Cell Clinics Network — three clinics in Southern California specializing in stem cell clinical trials that are funded by CIRM. They have more than 20 trials underway for conditions ranging from HIV to ovarian cancer, he says.
"If there’s something at one of those clinics, you know it’s legitimate and as safe as can be," McCormack says.
To find other stem cell clinical trials, start with the government-run clinicaltrials.gov database.
But be cautious. Some for-profit stem cell clinics post on that site, and patients who want to participate in their "studies" must pay for the cost of the treatment.
If you identify a trial that might fit your situation, do some digging, says Cathy Danielson, a stem cell patient advocate based in Oregon.
"Start asking questions, start posting on online forums," she says. "Ask who funded it. Follow the money."
Goldstein urges patients to look for trials that are conducted by academic medical centers or non-profit medical institutions, and to ask study sponsors if they have received FDA approval for their trials.
"Patients will recognize legitimate clinical trials because, in general, they won’t be charged for the cost of the treatment," he says.
Finally, if you find a trial, there’s no guarantee you’ll receive the experimental stem cell treatment. That’s because in most trials, some participants — chosen randomly — will receive either a placebo or the current standard of care, while others will get the experimental treatment.
In other words, there are obstacles to obtaining stem cell therapy at this point.
"But things are hopeful," Bass says.
"We’re really on the verge of great discoveries. The hard part is remembering to have the patience and understanding about the scientific discovery process."
This story was produced by Kaiser Health News, which publishes California Healthline, an editorially independent service of the California Health Care Foundation.
As Editor-in-Chief of our newsroom, I’m extremely proud of the work our top-notch journalists are doing here at LAist. We’re doing more hard-hitting watchdog journalism than ever before — powerful reporting on the economy, elections, climate and the homelessness crisis that is making a difference in your lives. At the same time, it’s never been more difficult to maintain a paywall-free, independent news source that informs, inspires, and engages everyone.
Simply put, we cannot do this essential work without your help. Federal funding for public media has been clawed back by Congress and that means LAist has lost $3.4 million in federal funding over the next two years. So we’re asking for your help. LAist has been there for you and we’re asking you to be here for us.
We rely on donations from readers like you to stay independent, which keeps our nonprofit newsroom strong and accountable to you.
No matter where you stand on the political spectrum, press freedom is at the core of keeping our nation free and fair. And as the landscape of free press changes, LAist will remain a voice you know and trust, but the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news from our community.
Please take action today to support your trusted source for local news with a donation that makes sense for your budget.
Thank you for your generous support and believing in independent news.

-
The bill would increase penalties for metal recyclers who possess or purchase metal used in public infrastructure.
-
The new ordinance applies to certain grocers operating in the city and has led to some self-checkout lanes to shutter.
-
Children asked to waive right to see a judge in exchange for $2,500
-
There’s still a lot to be determined as the refinery, which supplies about one-fifth of Southern California's vehicle fuels, works to restore production and as data is collected.
-
The FCC voted to end E-Rate discounts for library hotspot lending and school bus Wi-Fi.
-
About half the Pacific Airshow’s 2025 lineup has been grounded because of the federal government shutdown.